Last reviewed · How we verify

NCT05524493

High-field MR Imaging in Migraine, Visual Snow and Epilepsy

Recruiting now Last updated 8 October 2025
What this trial tests

trial testing Structural MRI in Migraine in 200 participants. Currently enrolling.

Timeline
1 March 2025
Primary endpoint
30 June 2026
30 June 2026

Quick facts

Lead sponsorUniversity of Zurich
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment200
Start date1 March 2025
Primary completion30 June 2026
Estimated completion30 June 2026
Sites2 locations across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University of Zurich

Who can join

Adults 18 to 65, any sex, with Migraine or Epilepsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this project, the aim is to recruit patients with drug resistant epilepsy and those suffering from migraine. Interestingly, patients suffering from epilepsy are also more often reporting to suffer from migraine. The pathobiology is understudied, but it is believed that both etiologies results from brain networks changes. A clinical certified 7T Terra Siemens scanner will be employed to assess in all participants (including healthy controls) how the microstructure differs in disease specific areas. Patients will further be clinically assessed as well as undergo questionnaires. Migraine is also a common comorbidity to visual snow syndrom and has been shown to impact similar brain regions. However, the pathophysiology is still understudied and a better understanding of the two diseases is needed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Structural MRI

Trials testing the same drug.

Other recruiting trials for Migraine

Currently open trials in the same condition.

Other University of Zurich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05524493.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing